Laryngeal Mask Airway Supreme Versus the Tracheal Tube as an Airway Device in Elective Laparoscopic Cholecystectomy
NCT ID: NCT02037958
Last Updated: 2014-01-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
76 participants
INTERVENTIONAL
2011-04-30
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Anaesthesia Requirement for Ventilation With Endotracheal Tube Versus Proseal Laryngeal Mask Airway
NCT03812718
Laryngeal Tube vs Laryngeal Mask Airway
NCT02607644
AuraGainTM and I-Gel® Laryngeal Masks in General Anesthesia for Laparoscopic Cholecystectomy
NCT02925598
Supreme LMA and Endotracheal Intubation Use in Caesarean Section
NCT01858467
Laryngeal Mask Airway Supreme Versus Laryngeal Tube
NCT02252120
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Laryngeal Mask Airway-Supreme
Patients who are randomly assigned to receive the LMA-Supreme
Laryngeal Mask Airway-Supreme
Patients who receive the LMA-S
Endotracheal Tube
Patients who are randomly assigned to receive endotracheal intubation
Endotracheal Tube
Patients who receive endotracheal intubation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Laryngeal Mask Airway-Supreme
Patients who receive the LMA-S
Endotracheal Tube
Patients who receive endotracheal intubation
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Undergoing elective laparoscopic cholecystectomy
Exclusion Criteria
* Known gastro-oesophageal reflux disease
* predicted or documented difficult airway
* contraindications to drugs in the standardized anaesthesia protocol
21 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Changi General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kelvin Quek How Yow
Consultant Anaesthetist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kelvin Quek, MMED (Anaes)
Role: PRINCIPAL_INVESTIGATOR
Changi General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Changi General Hospital
Singapore, Singapore, Singapore
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CGHLMAS2010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.